NDREVLA Trademark Information

Trademark by Revance Therapeutics, Inc

Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth musc...

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: NDREVLA
Status/Status Date:
ABANDONED - NO STATEMENT OF USE FILED
1/6/2020
Serial Number: 88175926
Filing Date: 10/31/2018
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 4/9/2019
Last Applicant/Owner:
Revance Therapeutics, Inc
Newark, CA 94560
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
KING & SPALDING LLP
1185 AVENUE OF THE AMERICAS
NEW YORK, NY 10036
Current Status:
ABANDONED - NO STATEMENT OF USE FILED
1/6/2020
Correspondent Search:
MAREN C. PERRY is a correspondent of NDREVLA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on